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In a preceding  communication  we  have demonstrated  that the relative 
immunogenicity of the murine H-7.1 alloantigen, as inferred from survival 
times of  H-7.1-incompatible skin grafts,  is  determined by genes in  the  D region 
of the major histocompatibility (H-2)complex (1).  Similar observations have 
been made previously  for  the male-specific  (H-Y) antigen by other investigators 
(2, 3). The effects  of  these  H-2.1inked  genes on the ability  of  non-H-2-incompat- 
ible  cells  to stimulate mixed lymphocyte culture (MLC)  I  reactions  or function 
as targets  for cytotoxic  effectors  have not been investigated. 
Extensive evidence has confirmed that the alloantigens  which most strongly 
stimulate T-lymphocyte proliferation  in  primary MLC are coded for  by genes in 
the H-2 complex (4) and more specifically  by genes in the  I region (5, 6). H-2K 
and H-2D alloantigens,  most notably those generated by recent mutations, are 
stimulatory in MLC, although to a lesser  degree than I  region MLC  determi- 
nants (6-9).  However, the only individual non-H-2 alloantigens  shown to be 
strongly stimulatory in primary MLC  are antigens coded for by alleles  at the 
Mls locus (10,  11).  Marginally significant  stimulation has been observed with 
single non-H-2  histocompatibility antigens  (12) and Thy-1  antigen  (13) in 
primary MLC.  Additional attempts, including ours reported in this paper, 
have not resulted in significant  stimulation by single non-H-2 antigens in 
primary MLC. 
In this  communication we report  that nylon wool purified,  splenic  T lympho- 
cytes obtained from donors primed with H-4- or H-7-incompatible spleen cells 
or  skin grafts,  proliferate  in  response to  incompatible lymphocytes in  secondary 
MLC. Further, we present  results  obtained in  experiments intended to  elucidate 
the role of H-2-1inked  genes in determining the relative ability  of H-7.1- 
incompatible lymphocytes to stimulate proliferation  in secondary MLC  and 
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generation of H-7.1-specific cytotoxic effector cells. The results reported herein 
demonstrate that both the relative stimulation capacity of H-7.1-incompatible 
lymphocytes in MLC and susceptibility of H-7.1-incompatible lymphoblasts to 
lysis  in  cell-mediated lympholysis are  controlled by  a  gene(s)  in  the H-2D 
region. 
Materials and Methods 
Mice.  The mice employed in this study and their respective genotypes are listed in Table I of 
the  preceding  paper  (1).  In  addition,  B10.129  (21M)  (referred  to  as  B10.129-H-4 ~)  mice  were 
derived from breeding stock provided by Dr.  George D.  Snell, of The Jackson Laboratory,  Bar 
Harbor, Maine. The BlO.129-H-4 b strain is congenic with B10, differs at only the H-4 locus (14) 
and  in  so  doing,  defines  the  H-4~:H-4 b  allelic  combination,  in  turn  the  H-4.1  and  H-4.2 
alloantigens (15, 16). 
MLC.  MLC conditions were modified from those described by Peck and Bach (17).  Protein- 
free  Click's  medium  was  prepared  as  described  (18)  with  the  exception  that  nucleic  acid 
precursors were omitted, Hepes added to a  concentration of 30 mM,  and penicillin-streptomycin 
replaced by gentamycin (Schering Corp.  Kenilworth, N. Y.).  Click's medium was supplemented 
with normal  mouse  serum  (collected  from  donors  syngeneic  with responder  cell  donors)  to  a 
concentration of 0.5%.  Stimulator cells were  obtained from spleen cell  suspensions after Tris- 
ammonium chloride treatment to lyse erythrocytes. The lymphocytes were treated with mitemy- 
cin C  (Sigma Chemical Co., St. Louis, Mo.) at a  concentration of 25 ~g/2  x  107 cells for 30 min, 
washed, and adjusted to a  concentration of 5  x  10  e viable cells/ml. Spleens from responder mice 
were  excised  and  reduced  to  a  single  cell  suspension.  Erythrocytes  were  lysed  with  Tris- 
ammonium chloride treatment and T lymphocytes were selected from the remaining lymphocyte 
population by passage over nylon wool columns according to the technique described previously 
(19).  B-cell contamination of nylon wool T-cell suspensions was monitored by direct immunofluo- 
rescence testing with fluoresceinated,  polyvalent goat anti-mouse immunoglobulin (Antibodies 
Inc.,  Davis,  Calif.).  B-cell contamination consistently varied between  5  and  10%;  suspensions 
with greater than  10%  B-cell contamination were discarded.  Responder cell  suspensions were 
adjusted to 5  x  106 viable cells/ml. Responder (5  x  105 cells) and stimulator (5  x  103 cells) cells 
were  mixed  in  0.20-ml  quadruplicate  cultures  in  wells  of microtiter plates  (Falcon  Plastics, 
Oxnard,  Calif.). Microtiter plates were placed in humidified Lucite boxes, gassed with 10% CO2, 
7%  O~,  and  83%  N2  (20),  and  incubated  at  37°C  for  3-5  days.  24  h  before  harvest,  2  ~Ci 
[3H]thymidine  (2  Ci/mM)  was  added  to  each  well  in  50  ~1  unsupplemented  Click's  medium. 
Lymphocytes were collected on glass fiber filters and washed with normal saline and methanol 
with the aid of a  semiautomatic cell harvester (Otto Hiller Co.,  Madison,  Wis.).  [3H]thymidine 
uptake  was  determined  by  using  a  scintillation  counter  (Beckman  Instruments,  Fullerton, 
Calif.).  Mean uptake (-+ standard error) in quadruplicate wells was calculated. The significance 
of differences between means of allogeneic and syngeneic cultures was determined by Students' t 
test assuming equal variance (21).  Antigen-specific uptake  (allogeneic mean-syngeneic mean) 
in allogeneic cultures was calculated when the allogeneic mean was significantly greater than 
the syngeneic mean at P  <  0.001. 
Cell-Mediated  Lympholysis.  The  cell-mediated  lympholysis  assay  was  a  short  term  5'Cr 
release assay performed as described (22).  Effector cells were prepared by coculturing responder 
and stimulator cells at a  1:1 ratio for 5 days under conditions similar to those employed for the 
MLC assay; 5 ml of each suspension were mixed in 60-ram Petri dishes. Surviving lymphocytes 
were washed in RPMI-1640 (Grand Island Biological Co., Grand Island, N. Y.) supplemented with 
5% heat-inactivated fetal calf serum and the cell concentration adjusted to 2  ×  106 viable cells/ 
ml.  Lymphoblast targets were prepared by incubating spleen cells (3  ×  106 cells/ml) in RPMI- 
1640 supplemented with concanavalin A (2 ~g/ml) (Calbiochem, La Jolla, Calif.) for 3 days. Blast 
cells were partially purified by differential centrifugation at 50 g  and subsequently labeled with 
5~Cr. Labeled lymphoblasts were washed five times and adjusted to  1  ×  10  ~ cells/ml.  One-half 
milliliter of effector and 5~Cr-labeled target cell suspensions were mixed in 35-mm plastic dishes 
in an effecter: target ratio of 20:1.  The dishes were placed in a humidified Lucite box, gassed with 
10% CO2,  7% 02, and 83% N2, rocked (seven cycles/minutes), and incubated at 37°C for 4 h. The 
cell suspensions were transferred to tubes and spun at 450 g  for 10 min. One-half milliliter was 1358  H-2D  CONTROL  OF  H-7.1  IN  VITRO  IMMUNOGENICITY 
TABLE  I 
The Lack of Proliferative Response of BlO Normal Spleen Cells to H-4 £-Incompatible 
Stimulators in Primary MLC 
Stimulator  Relevant H  locus 
cell  incompatibility 
Mean [3H]uptake ±  SE at 
3 days  4 days  5 days 
B10.129-H-4 b  H-4  1,762  -  359  1,919  ±  511  1,613  ±  361 
B10.A(1R)  H-2  11,617  ±  1,666  18,973  ±  1,761  19,978  ±  1,297 
B10  None  1,763  ±  199  2,206  ±  517  1,714  ±  219 
-  -  1,107  -  72  1,377  ±  583  1,104  ---  326 
removed from each sample for counting in a  well-type gamma counter (Beckman Instruments, 
Fullerton, Calif.).  Percent release was determined by the following formula: 
experimental cpm-spontaneous cpm (targets alone) 
Percent specific release =  total releasable cpm-spontaneous cpm (targets alone)  ×  100 
Immunization Regimen.  Responder  cells  for the  tests  for H-2D  dependence  of stimulatory 
capacity of H-7.1-incompatible stimulators in MLC were obtained from (BIO.C(H-2~)-H-7  b x  B10- 
H-2~H-7b)F~ recipients  of primary-quaternary  H-7.1-incompatible  skin  grafts.  These  grafting 
procedures  have  been  described  in  detail  in  the  preceding  communication  (1).  Spleens  were 
excised 4 wk after quaternary grafting.  T  lymphocytes purified by passage through nylon wool 
columns served as both responders for MLC and precursors for cytotoxic effectors in CML. 
Results 
Primary and Secondary MLC Responses to Single Non-H-2 Histocompatibil- 
ity Antigens.  To determine if primary MLC responses could be detected in 
this test system, normal B10 responder spleen cells were mixed with H-4.2- 
incompatible stimulator cells from B10.129(H-2 ~)-H-4 b donors and the resulting 
proliferation  measured  by  [3H]thymidine  incorporation.  These  results  are 
presented  in  Table  I.  No  significant proliferation was  observed in  primary 
MLC. Significant proliferation was observed when the same cells were stimu- 
lated by H-2-disparate stimulators. To amplify the frequency of H-4.2-specific 
responder lymphocytes in responder populations, responding cell donors were 
primed in vivo with either multiple sets of H-4.2-incompatible skin grafts or a 
single  intraperitoneal  injection  of varying  numbers  (1-20  ×  106) of H-4.2- 
incompatible spleen cells. Spleens excised 1 wk after graft rejection or injection 
were the  source of responder lymphocytes. The responder spleen cells were 
mixed with syngeneic and H-4.2-incompatible stimulators. The results of these 
assays  are  presented in Table  II.  Spleen cells obtained from donors primed 
with  either  H-4.2-incompatible  skin  grafts  or  lymphocytes responded with 
significant proliferation to H-4.2-incompatible stimulators, thus demonstrating 
the utility of priming with either skin grafts or spleen cells. To determine if 
the specific response could be improved by using purified responder T cells the 
response of splenic T  lymphocytes obtained from B10  donors primed with a 
single injection of 10 ×  10  e H-4.2-incompatible BlO.129(H-2O)-H-4 b spleen cells 
was tested 7 days postinjection. The results of this assay are included in Table 
II. Responder T cells were observed to proliferate in response to H-4.2-incompat- 
ible  stimulators,  suggesting that  the responding cells in the spleen were T 
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TABLE  II 
Proliferative Response of BlO Spleen Cells after Challenges of Varying Numbers of BlO.129- 
H-4 b Spleen Cells 
Immunizing  Immunizing  Stimulator 
cells  dose  cells 
Mean [~H]uptake (cpm ±  SE [4*]) 
3 days  4 days  5 days 
Skin allografts  Three sets  B10.129-H-4  b  5,261  ±  1,023 (3,168)  9,589  ±  2,473  (7,969)  25,040  ±  1,550 (21,594) 
B10.A(1R)  NT~  NT  NT 
B10  2,093  ±  444  1,820  ±  393  3,446  ±  565 
-  1,380  ±  155  1,427  ±  375  2,165  ±  670 
Spleen cells  1 x  10  e  B1O.129-H-4 ~  2,834  ±  484  (1,277)  1,576  ±  76  (988)  1,821  ±  113  (1,126) 
B10.A(1R)  12,861  ±  837  (11,509)  21,264 ±  2,879 (20,680)  27,776 ±  2,527 (27,081) 
B10  1,357  ±  36  588  ±  205  695  ±  251 
-  947  ±  57  862  ±  299  726  ±  231 
Spleen cells  5  x  108  B10.129-H-4  b  4,753  -+  215  (2,731)  6,747  ±  1,236 (4,221)  8,483  ±  2,317  (5,899) 
B10.A(1R)  15,124  ±  951  (13,109)  23,394  ±  2,140 (20,868)  24,240 ±  809  (21,656) 
B10  2,022  ±  317  2,526  ±  443  2,584  ±  900 
-  1,462  ±  164  1,856  ±  419  3,392  ±  531 
Spleen cells  10 x  10  ~  B10.129-H-4  b  5,058  ±  851  (2,962)  10,463  ±  1,526 (7,869)  9,238  ±  1,446 (5,846) 
B10.A(1R)  13,526  ±  2,402 (11.430)  21,067  -+  2,524 (18,473)  18,862  ±  2,028 (15,470) 
B10  2,096  ±  251  2,594  ±  221  3,392  ±  531 
-  1,611  ±  145  1,689  ±  140  2,034  ±  195 
Spleen cells  20 x  10  e  B10.129-H-4  ~  9,076  _+  1,686 (6,584)  9,168  ±  1,044 (5,878)  8,010  ±  1,401 (4,560) 
B10.A(1R)  14,289  ±  1,442 (11,797)  20,061  ±  2,029 (16,771)  17,445  ±  762  (13,995) 
B10  2,492 ±  230  3,290  ±  583  3,450  ±  892 
-  1,705  ±  268  2,390  ±  291  2,538  ±  160 
Spleen cells  10 x  10  e  B10.129-H-4  ~  1,925  ±  210  (1,521)§  3,004  ±  251  (2,507)  4,903  -*  1,415 (4,344) 
B10.A(1R)  NT  NT  NT 
B10  404  ±  75  497  ±  1,200  559  ±  160 
-  284  ±  127  818  ±  202  157  ±  76 
* ~  computed when mean uptake is significantly different from syngeneic combinations at P  <  0.001. 
t  Not tseted. 
§ Response of nylon wool purified T cells. 
stimulatory in  MLC,  although  in  vivo priming is  required,  presumably to 
increase the frequency of antigen-specific responder T cells to a level detectable 
by [3H]thymidine uptake. 
H-2D Control of  Stimulatory Capacity of  H-7.1-Incompatible Stimulators.  In 
a  companion paper we presented evidence indicating that a  gene(s) in the H- 
2D region regulates the relative rejectability of H-7.1-incompatible skin grafts 
(1). We have further investigated the possible role of this gene in regulating 
the ability of H-7.1-incompatible spleen cells to stimulate proliferation in MLC. 
Preimmunized  (BIO.C(H-2b)-H-7  b  x  BIO-H-2aH-7b)F1  responder  cells  were 
mixed with H-7.1-incompatible, H-2-compatible stimulator cells from donors 
with different H-2  haplotypes.  The results of these assays  are  presented in 
Table HI.  B10 stimulators cells were optimally stimulatory (h  =  28,505  at 5 
days) whereas B10.A stimulators were comparatively ineffective (h =  2,186 at 
5 days). To insure that proliferation of F1 responder cells was H-7.1-specific and 
not  specific  for  Hh-1  determinants  (23,  24)  expressed on homozygous H-2 b 
stimulators, two controls were performed. First, B10.C(H-2 b)-H- 7 ~ and B10-H- 
2all-7 b parental strain spleen cells were tested for stimulation and were found 
to  be  equally  nonstimulatory.  These  cells  are  H-7  compatible  but  should 
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TABLE  HI 
Proliferative Response of (BI O.C-H- 7 b x  BI O-H-2~H- 7~)  FIT L ymphocytes Primed with 
Multiple Graflings of H-7.1-Incompatible Grafts 
Stimulator  Origins of H-2 subregions  Mean [SH]uptake (cpm  ±  SE [h*]) 
cell 
donor  K  A  B  J  E  C  S  D  Tla  H-7  3 days  4 days  5 days 
C67BL/10  b  b  b  b  b  b  b  b  b  a  8,944 -+ 749  (7,282)  18,756  ±  3,033  (17,319)  30,121  --- 3,693  (28,505) 
B10.A  k  k  k  k  k  d  d  d  a  a  2,557  ±  426  (89{;)  2,766 --_ 533  (1,328)  3,802  ±  2,180 (2,186) 
(B10.A ×  b~  b~  b~  b~  b~  b~  b/  b~  b~  a  7,312  ±  983  (5,650)  13,815  -+ 1,382 (12,378)  20,706  ±  3,368  (19,090) 
B10)F~  k  k  k  k  k  d  d  d  a 
B10.A(1R)  k  k  k  k  k  d  d  b  b  a  7,547  +  1,140(5,885)  15,733  ±  1,311 (14,296)  18,521  ±  2,633  (16,905) 
B10.A(4R)  k  k  b  b  b  b  b  b  b  a  8,352  ±  871  (6,690)  15,950  -  1,988 (14,513)  23,220  -  1,118 (21,604) 
B10.A(6R)  b  b  b  k  k  d  d  d  a  a  1,891  ±  177  2,159 +  355  (722)  2,725 ±  647  (1,109) 
B10.A(18R)  b  b  b  b  b  b  b  d  a  a  4,655 ±  564  (2,993)  7,124  ±  1,662 (5,687)  13,469  ±  1,158 (11,853) 
B6-T/a  a  b  b  b  b  b  b  b  b  a  a  8,163  ±  1,679(6,501)  17,950  ±  4,432 (16,468)  32,846  ±  6,843 (31,230) 
BIO-H-2~H-7 ~  k  k  k  k  k  d  d  d  a  b  1,323  ±  269  1,176  ±  184  1,090  -+ 152 
B10.C-H-7  b  b  b  b  b  b  b  b  b  b  b  1,662  -+ 241  1,437 ±  71  1,616  ±  72 
993 ±  194  537 ±  32  383  ±  140 
* h computed when mean is significantly different from the mean for the combination of (B10.C-H-7  ~ x  BIO-H-2~H-7O)F~ + B10.C-H-7  b at 
P  <  0.001. 
respectively. Second,  (B10  ×  B10.A)F~ spleen cells which should not express 
Hh-1  determinants  but  do  express  the  relevant  H-7.1  antigen  effectively 
stimulated proliferation in MLC. These results confirmed that the differential 
proliferative response of (BIO.C(H-2b)-H-7 b  x  BIO-H-2~H-7b)F1  responders to 
B10  and  B10.A  stimulators  was  H-7.1-specific  and  not  Hh-l-specific.  The 
relatively high  stimulation  capacity of B10  stimulators was  inherited as  a 
dominant trait. The map position of the gene controlling the relative stimula- 
tion capacity of H-7.1-incompatible stimulators was determined through the 
use of stimulator cells from mice with H-2 haplotypes derived from intra-H-2 
recombinations between H-2 ~ and H-2 b. Spleen cells obtained from B10.A(1R) 
and B10.A(4R)  donors stimulated proliferation to a  level comparable to that 
induced by B10 stimulators (Table III).  However, B10.A(5R) spleen cells were 
similar in stimulatory capacity to B10.A spleen cells.  The haplotype origins of 
the H-2  regions of these H-2  recombinants (Table III) suggests that the gene 
controlling the efficacy of H-7.1-incompatible stimulatorsmaps in the region 
telomeric to the H-2 ~  recombination site. 
The  high  proliferation induced by  B6-Tla  a  spleen  cells further maps  the 
gene  to  the D  region  as  defined by  the  H-2 ~  recombination  site  on  the 
centromeric side and the site of the recombination separating H-2 ~ and Tla a 
in the production of B6-Tla a on the telomeric side. It should be noted that B6- 
Tla a differs from B10 at a minimum of one non-H-2 H  locus independent of H- 
2  (25) and at H-31  and H-32  linked to H-2  (26). The Tla ~ allele derived from 
the H-2 a haplotype is shared by BIO-H-2aH-7 b and B6-T/a% therefore comple- 
menting for the H-31  and H-32  alleles of B6-Tla ~ which map in the H-2D-Tla 
interval  (27). The inability to detect proliferation in primary MLC  to single 
non-H-2  H antigens makes a  primary response to non-H-2  H  antigens of B6- 
Tla a not shared with B10 highly unlikely. The single exception to the D region 
map position of the operative regulatory gene is the stimulatory capacity of 
B10.A(18R) spleen cells. B10.A(18R) spleen cells were intermediate stimulators 
(A = 11,853 cpm at 5 days) despite the fact that they are H-2Da; this observation 
suggests that the control of stimulating capacity of H-7.1-incompatible stimula- P.  J.  WETTSTEIN  AND  J.  A.  FRELINGER  1361 
TABLE  IV 
H-2 Determination of Capacity of H-7.1-Incompatible  Stimulators to Boost for 
Restricted Lysis of H-7.1-Incompatible  Targets 
Boosting  Mean percent lysis of 5~Cr lymphoblast targets 
stimulator 
cells  B10  B10.A  (B10.A ×  B10)F,  B10.A(1R)  B10.A(SR)  B6-Tla"  B10.C.H-7  ~ 
B10  39  0*  46  70  9  45  0 
B10.A  0  0  23  41  5  20  0 
(B10.A x  B10)F~  45  0  52  67  10  41  0 
B10.A(1R)  45  0  55  61  7  44  0 
B10.A(5R)  0  0  0  3  8  8  0 
B10.C-H-7  ~  0  0  0  0  6  7  0 
* Specific release _< spontaneous release. 
tors may be under multigenic control by genes in the S-D  interval. The 18R 
recombinant could then be assumed to carry one of the high stimulation genes 
derived from the H-2 b haplotype which would map to the centromeric side of 
the H-2 i18 recombination site, and to carry a low stimulation gene derived from 
the H-2a  haplotype mapping in the D  region as bounded on the centromeric 
side  by  the  H-2 i1~  recombination, site.  The  other  alternative  is  that  the 
B10.A(18R) strain carries a mutation in the gene governing stimulation ability 
and represents either a change from low (H-2 ~) to intermediate (new allele) or 
high (H-2 o) to intermediate (new allele). 
H-2D Control of Stimulation  of Generation of H-7.1-Specific  Cytotoxic Effec- 
tor Cells.  We determined the effects of H-2D genotype on the effectiveness of 
H-7.1-incompatible  spleen  cells  in  stimulating  generation  of H-7.1-specific 
effectors and susceptibility of H-7.1-incompatible lymphoblast targets to lysis. 
Preimmunized (BIO.C{H-2~)-H-7 b  ×  BIO-H-2aH-7~)F1  responder nylon wool T 
cells were stimulated with H-7.1-incompatible stimulators from donors with 
different H-2 haplotypes in macro MLC and the surviving cells tested for their 
ability to lyse H-7.1-incompatible, ~lCr-labeled lymphoblast targets. The results 
of these CML  assays are presented in Table IV.  The important observations 
may be summarized as follows:  (a) H-7.1-incompatible stimulators possessing 
H-2D b more effectively stimulated generation of H-7.1-specific  cytotoxic effec- 
tors than H-2D d homozygous stimulators and (b) H-7.1-incompatible, lympho- 
blast targets possessing the H-2D region of H-2 ~ were sensitive to detectable H- 
7.1-specific lysis whereas targets homozygous for the H-2D region of H-2 ~ were 
not. It is particularly important to emphasize that coexpression of H-7 a and H- 
2D b  by  lymphoblast  targets  is  essential  for  susceptibility  to  H-7.1-specific 
cytotoxic activity.  The reciprocal H-2  restriction  (involving F1  effector lysis 
exclusively of targets sharing the H-2 haplotype of the boosting cells) of the type 
reported for non-H-2  H  antigens  was  not  observed with  H-7.1-incompatible 
lymphoblast targets. Targets must express H-2D b and share a segment of the 
H.2  complex  with  the  MLC  stimulators  and  express  H-7 ~.  Of  particular 
interest was the observation that effectors boosted by B10.A stimulators lysed 
B6-Tla ~ targets. Although B6-Tla ~ and B10.A differ at both H-2K and H-2D, 
they share the genes in the region telomeric to the recombination splitting H- 
2D b and Tla ~ in the selection of B6-Tla ~.  This result would suggest that the 
identity between MLC stimulator and CML target was not required at H-2D 
but rather at a locus telomeric to H-2D. H-2  identity between stimulator and 1362  H-2D  CONTROL  OF  H-7.1  IN  VITRO  IMMUNOGENICITY 
target without target expression ofH-2D ~ is simply not sufficient for detectable 
lysis  as  demonstrated  by  the  inability  of B10.A  stimulators  to  boost  for 
detectable lysis of B10.A lymphoblast targets  (Table IV).  It is interesting to 
note that while B10.A stimulators cannot stimulate the production of cytotoxic 
cells which can kill B10.A targets, they do stimulate the production of effectors 
which can  kill  cells  which express H-2D ~  and  share  a  portion of the H-2 
complex with H-2 a.  Thus  (B10  ×  B10.A)F1,  B10.A(1R),  and B6-T/a ~ targets 
are lysed by effectors stimulated by B10.A cells whereas B10 and B10.A targets 
are not.  The inability of B10.A(5R) to stimulate generation of H-7.1-specific 
cytotoxic effectors suggests that such stimulation by H-2D d  stimulators may 
require simultaneous expression in the stimulator of an H-2 a allele at a locus 
centromeric to the H-2  ~5 recombination site and H-2D d. 
Discussion 
In  this  communication we  have  shown  that  stimulator  cells  differing at 
single non-H-2 histocompatibility (H) loci (H-7 and H-4) stimulate significant 
proliferation  of  responder  T  lymphocytes  in  secondary  mixed  lymphocyte 
culture. In addition, the stimulatory capacity of H-7.1-incompatible stimulators 
and susceptibility of targets to lysis are regulated by a  gene(s) in the H-2D 
region. It would appear that in vivo priming is required to expand the number 
of T cells-specific for single non-H-2 H antigens enabling detection of prolifera- 
tion in MLC. This supposition would predict that the frequency ofT lymphocytes 
responsive to alloantigens in MLC range in frequency from those T  cells in 
relatively high frequency, responsive to I  region determinants and Mls anti- 
gens, to those T cells responsive to single non-H-2 histocompatibility alloanti- 
gens  normally  present  in  relatively  low  frequency.  The  relative  levels  of 
proliferation in MLC across H-2 and HLA barriers were believed to correlate 
inversely with the probability of graft rejection across the same barriers, until 
a lack of correlation was shown, initially for HLA(28) and subsequently for H-2 
(5). On the contrary, the results in this communication and preliminary data on 
Ir gene control of the response to single non-H-2 H antigens demonstrate that 
relative  levels  of proliferation  in  secondary  MLC  inversely  correlate  with 
relative survival times of skin allografts transplanted across the same non-H-2 
H barriers. The survival time of H-4.2-incompatible skin grafts is dependent on 
recipient H-2  genotype  (29); H-2 b  and H-2 d  recipients  are  fast  responders 
whereas H-2 a  recipients are  slow responders.  Splenic T  cells obtained from 
primed H.2 ~  and H-2 d  donors proliferate  in  response to  H-4.2-incompatible 
stimulators in secondary MLC whereas H-2 a T  cells do not (P. J.  Wettstein, 
unpublished observations). 
The actual stimulator cell in mitomycin C-treated, H-7.1-incompatible spleen 
cell suspensions has not been identified. It has been inferred that non-H-2 H 
antigens are  expressed on macrophages, based on the observations that:  (a) 
non-H-2-incompatible hyperimmune spleen and peritoneal exudate cells (which 
transfer  anti-SRBC  immunity) are  inactivated by recipients in  vivo  (30-33) 
and (b) the cells actually required for transfer of immunity are macrophages 
(34). We are presently investigating the identity of the actual cell stimulating 
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non-H-2  H  antigen-specific proliferation may be  analogous to  stimulation of 
guinea pig T cells by antigen-pulsed macrophages (30). If this situation were 
the case, an extensive study of this in vitro response may yield important in- 
formation regarding the genetic control of macrophage:T cell and target:effector 
interactions. 
The antigenic specificity of H-2D control of relative immunogenicity of non- 
H-2 H antigens is presently unknown. We are examining the effects of H-2D 
region genes on the immunogenicity of H-4, H-3, and H-Y alloantigens. It has 
been suggested that H-Y immunogenicity is controlled by a gene(s) in the H- 
2K  end (c) although the data do not strongly support the proposed mapping. 
However, H-2D control of susceptibility of H-Y-positive lymphoblast targets to 
H-Y-specific  lysis would account for the difference in susceptibility of B10.A 
and B10.A(2R) male targets (35) previously suspected to be the result of H-2D- 
linked restriction. If, as we suspect, the H.2 control of relative immunogenicity 
is  not  limited to  the  H  antigens  studied to  date,  this  phenomenon will be 
important for the study of the response to non-H-2 H antigens in general. H-2 
restricted in  vitro cytotoxicity specific for multiple non-H-2 H  antigens  (36) 
could be partially accounted for by differential control of immunogenicity of 
subsets of non-H-2 H antigens by different  H-2 haplotypes. 
If the experiments, in which responders are stimulated by a complex array of 
H antigens, represented a general case for single H antigens, one would have 
expected reciprocal restriction of H-7.1-specific effectors. In this communication 
we have demonstrated that splenic T cells removed from animals primed to H- 
7.1  and  boosted  in  vitro  can  produce  H-2-restricted  cytotoxic  cells  when 
stimulated by H-7.1-incompatible stimulators possessing H-2D ~. The resistance 
of H-2D a  homozygous, H-7.1-incompatible targets  to  lysis  places  important 
limitations on the restriction in vitro since H-2D d homozygous stimulators can 
not boost for cytotoxic effectors capable oflysingH-2D  d targets. These generated 
effectors can lyse H-2D~-bearing  targets if they shar.  e part of the H-2 a haplo- 
type,  suggesting classical  restriction is  operative in  vitro but  in  a  manner 
considerably more complex than predicted by any current restriction theory, 
either altered self or dual recognition. The unexpected observation that H-7.1- 
specific  effector cells generated by boosting with B10.A stimulators lysed B6- 
Tla" targets suggests that the previously observed requirement for sharing K 
or D regions between killer and target is not absolute and can also be satisfied 
by products of a locus telomeric to H-2D in the Tla region. Further experiments 
are required to confirm this observation and to map the locus responsible for 
restriction of H-7.1°specific  effectors relative to the other genes in the D-Tla 
interval. The discrepancy between in vivo and in vitro results indicates that 
rechallenge with non-H-2-incompatible stimulators in vitro results in either a 
differentiation of previously unrestricted cytotoxic T  cells into  T  cells with 
restricted cytotoxic activity or selective amplification of a subset of cytotoxic T 
cells preferentially reactive with targets expressing a particular H-2 haplotype. 
Selective depletion of proliferating T  cells in  MLC  through the use of high 
levels of [3H]thymidine or treatment with bromodeoxyuridine and light and 
restimulation of the remaining cells should allow us to discriminate between 
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Summary 
The relative  immunogenicity of  the H-7.1 alloantigen has been shown in a 
previous communication to  be regulated by a gene in  the  D region of  the mouse 
major histocompatibility  (H-2)  complex. The level  of  relative  immunogenicity 
was inferred  from survival  times of  H-7.1-incompatible skin grafts  donated by 
donors with different  H-2 haplotype  origins of H-2D region genes. In this 
communication we report  the results  of  an extension of  these previous investi- 
gations into  the possible  role  of  H-2D region genes in controlling  the capacity 
of  H-7.1-incompatible  lymphocytes to  stimulate  H-7.1-speciflc  mixed lymphocyte 
culture proliferation  and generation of cytotoxic effector  cells.  The results 
reported herein demonstrate that the H-2D genotype of H-7.1-incompatible 
stimulator  cells  determines the  relative  H-7.1-specific  capacity  of  those lympho- 
cytes to stimulate H-7.1-specific  proliferation  of in vivo primed responder T 
cells  in secondary mixed lymphocyte culture.  H-2Db-bearing,  H-7.  l-incompati- 
ble stimulators were significantly  more effective  in stimulating H-7.1-specific 
proliferation  than H-2Dd-bearing stimulators.  As expected,  H-2D  b, H-7.1-in- 
compatible stimulators were also more effective  than H-2D  a stimulators in 
generating H-7.1-specific  cytotoxic  effector  cells.  Further, the susceptibility  of 
~Cr-labeled,  H-7.1-incompatible lymphoblast targets  to  H-7.1-specific  lysis  was 
similarly  regulated by an H-2D gene.  Reciprocal  H-2 restriction  (F~ cells  are 
capable of killing  only the cells  bearing the immunizing cell  parental H-2 
haplotype)  observed by other  investigators  for  cytolysis  of  non-H-2-incompatible 
targets  was not  observed.  H-2D  a-bearing,  H-7.1-incompatible stimulators  stim- 
ulated generation of  cytotoxic  effectors  capable of  detectably  lysing  H-2D  b  but 
not H-2Da-bearing,  H-7.1-incompatible targets.  The impact of these observa- 
tions  on the proposed models for  H-2 restriction  of  non-H-2 histocornpatibility 
antigen-specific  cytolysis  is  discussed. 
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